Suivre
Shivan Sivakumar
Shivan Sivakumar
Adresse e-mail validée de bham.ac.uk
Titre
Citée par
Citée par
Année
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
LYW Lee, JB Cazier, T Starkey, CD Turnbull, UKCCMP Team, R Kerr, ...
The Lancet, 2020
12602020
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ...
The Lancet Oncology 21 (10), 1309-1316, 2020
6602020
HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value–conclusions from 924 cases of two independent series
H Grabsch, S Sivakumar, S Gray, HE Gabbert, W Müller
Analytical Cellular Pathology 32 (1-2), 57-65, 2010
4052010
Evaluation of pre-analytical factors affecting plasma DNA analysis
H Markus, T Contente-Cuomo, M Farooq, WS Liang, MJ Borad, ...
Scientific reports 8 (1), 1-10, 2018
1382018
Biomarkers of response to PD-1 pathway blockade
H Li, PA van der Merwe, S Sivakumar
British Journal of Cancer, 1-13, 2022
1102022
Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma.
X Tan, S Sivakumar, J Bednarsch, G Wiltberger, JN Kather, J Niehues, ...
Oncogene, 2020
782020
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
I Anil, R Arnold, S Benkwitz-Beford, S Branford, N Campton, JB Cazier, ...
The Lancet Oncology 21 (5), 622-624, 2020
712020
Cell-free DNA TAPS provides multimodal information for early cancer detection
P Siejka-Zielińska, J Cheng, F Jackson, Y Liu, Z Soonawalla, S Reddy, ...
Science Advances 7 (36), eabh0534, 2021
602021
Master regulators of oncogenic KRAS response in pancreatic cancer: an integrative network biology analysis
S Sivakumar, I de Santiago, L Chlon, F Markowetz
PLoS medicine 14 (1), 2017
502017
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
I De Santiago, C Yau, L Heij, MR Middleton, F Markowetz, HI Grabsch, ...
International journal of cancer 145 (4), 1125-1137, 2019
492019
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
S Sivakumar, E Abu-Shah, DJ Ahern, EH Arbe-Barnes, AK Jainarayanan, ...
Cancers 13 (8), 1776, 2021
392021
Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
JJ Jaworski, RD Morgan, S Sivakumar
Cancers 12 (12), 3704, 2020
252020
Collective intelligence for translational medicine: Crowdsourcing insights and innovation from an interdisciplinary biomedical research community
E Jane Budge, S Maria Tsoti, D James Howgate, S Sivakumar, M Jalali
Annals of medicine 47 (7), 570-575, 2015
232015
A New Combination Immunotherapy in Advanced Melanoma
AE Frampton, S Sivakumar
New England Journal of Medicine 386 (1), 91-92, 2022
192022
Nerve Fibers in the Tumor Microenvironment Are Co-Localized with Lymphoid Aggregates in Pancreatic Cancer
LR Heij, X Tan, JN Kather, JM Niehues, S Sivakumar, N Heussen, ...
Journal of Clinical Medicine 10 (3), 490, 2021
182021
Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study
P San Tan, C Garriga, A Clift, W Liao, M Patone, C Coupland, ...
Gut, 2022
172022
Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma
J Bednarsch, J Kather, X Tan, S Sivakumar, C Cacchi, G Wiltberger, ...
Liver Cancer 10 (3), 260-274, 2021
172021
Tumor heterogeneity: does it matter?
C Turnquist, RA Watson, A Protheroe, C Verrill, S Sivakumar
Expert review of anticancer therapy 19 (10), 857-867, 2019
162019
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
T Chouari, FS La Costa, N Merali, MD Jessel, S Sivakumar, N Annels, ...
Cancers 15 (17), 4265, 2023
122023
The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma
J Bednarsch, X Tan, Z Czigany, D Liu, SA Lang, S Sivakumar, JN Kather, ...
Cancers 13 (15), 3661, 2021
122021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20